Clinical Trial Update: Diindolylmethane in Treating Patients With Abnormal Cervical Cells [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating diindolylmethane for abnormal cervical cells has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Diindolylmethane (diindolylmethane)

Snippet

Sponsor: Barts and the London School of Medicine and Dentistry | Conditions: Cervical Cancer, Precancerous Condition | Phase 3 | Status: COMPLETED